SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LCTX

Lineage Cell Therapeutics, Inc. (LCTX)

NYSE: LCTX · Real-Time Price · USD
Healthcare · Biotechnology
$0.80-$0.12 (-13.07%)
 
Market cap
$201M
Insider Score
Analyst consensus
Insider Score
76/ 100
LCTX Insider Score
Bullish

1 qualifying trade · 1 insider · $17.10K bought in the last 90 days

LCTX analyst forecast

No analyst ratings in the last 12 months

No independent sell-side analyst publishes on LCTX that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:

Best analysts covering LCTX

No firm covering LCTX has a call old enough to have finished a 1Y holding period yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.